Standout Papers
Citation Impact
Citing Papers
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Bile in the oesophagus: clinical relevance and ambulatory detection.
1997
Associations between different forms of gastro-oesophageal reflux disease
1997
The gut microbiota and host health: a new clinical frontier
2015 Standout
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
1998
Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis
2014
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
2015
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease
2011
Gastric cancer
2016 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Review article: prevalence and epidemiology of gastro‐oesophageal reflux disease in Japan
2004
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin
2008
Osteoporosis
2019 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Functional Gastroduodenal Disorders
2006 Standout
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
2019
Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks
2008
AGA technical review: Evaluation of dyspepsia
1998
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Lansoprazole Treatment of Patients With Chronic Idiopathic Laryngitis: A Placebo-Controlled Trial
2001
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
2017
Helicobacter pylori and gastric diseases
1998
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma
2011
Clinical characteristics and natural history of patients with low‐grade reflux esophagitis
2002
Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging
2007
Review article: Barrett's oesophagus and carcinoma in Japan
2004
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
2015
Guillain-Barré syndrome
2016 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
2008
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
2018
Esophageal Histology Does Not Provide Additional Useful Information Over Clinical Assessment in Identifying Reflux Patients Presenting for Esophagogastroduodenoscopy
2000
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial
2009
Systemic sclerosis
2017 Standout
Detection of Barrett's Esophagus After Endoscopic Healing of Erosive Esophagitis
2006
Management of Acute Bleeding from a Peptic Ulcer
2008
Trends in Management and Outcomes of Acute Nonvariceal Upper Gastrointestinal Bleeding: 1993–2003
2006
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Colorectal cancer
2013 Standout
Report of the Asia–Pacific consensus on the management of gastroesophageal reflux disease
2004
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
Guidelines for the Management of Dyspepsia
2005
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
Colorectal cancer
2019 Standout
Predictive value of alarm features in a rapid access upper gastrointestinal cancer service
2004
Dual Therapy Versus Monotherapy in the Endoscopic Treatment of High-Risk Bleeding Ulcers: A Meta-Analysis of Controlled Trials
2007
Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies
2007
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease
2004
Sleep dysfunction in patients with gastro‐oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study
2004
Meta‐analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy
2004
Helicobacter pylori-associated diseases
2002
Control of Gastric Acid Secretion in Health and Disease
2008
Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group
2005
Crohn's disease
2016 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
2017
Oesophageal carcinoma
2013 Standout
Necrotizing Enterocolitis
2011 Standout
Systemic Lupus Erythematosus
2011 Standout
A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
2015
Symptom Patterns and Pathophysiological Mechanisms in Dyspeptic Patients with and Without Helicobacter pylori
2003
Disease Activity Assessment in IBD
2015
Do We Need Gastric Acid?
2008
Simple Clinical Predictors May Obviate Urgent Endoscopy in Selected Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding
2007
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
2015
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
1996
Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases
2015
Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Barrett's oesophagus
2009
Ulcerative colitis
2016 Standout
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?
2005
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Dysphagia in patients with erosive esophagitis: Prevalence, severity, and response to proton pump inhibitor treatment
2004
Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus
1996
Function-Preserving Gastrectomy for Early Gastric Cancer
2013
Gastric diffusion of antibiotics used against Helicobacter pylori
1998
Prevalence and Distribution of Helicobacter Pylori in Gastroesophageal Reflux Disease: A Study From The East
1999
Treatment of functional dyspepsia
2005
Gastric cancer
2020 Standout
Candidiasis
1989
Helicobacter pyloriInfection
2002 Standout
Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
Brazilian Consensus on Gastroesophageal Reflux Disease: proposals for assessment, classification, and management
2002
Biomarkers of Inflammation in Inflammatory Bowel Disease
2015
Ulcerative colitis
2020 Standout
Barrett's Esophagus
2009
Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases
2005
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Neutrophil Extracellular Traps in Ulcerative Colitis
2015
Risk Factors for the Severity of Erosive Esophagitis in Helicobacter pylori -Negative Patients with Gastroesophageal Reflux Disease
2002
The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids.
1995
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities
2016
Multilayered epithelium at the gastroesophageal junction is a marker of gastroesophageal reflux disease: data from a prospective Central European multicenter study (histoGERD trial)
2014
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
2004
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
2015
Review of deep learning: concepts, CNN architectures, challenges, applications, future directions
2021 Standout
COX-2 inhibitors
1999 Standout
Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma
2006
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial
2015
Surgical trial investigating nocturnal gastroesophageal reflux and sleep (STINGERS)
2002
Pediatric short-bowel syndrome: the cost of comprehensive care
2008
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
2007
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Hepatocellular carcinoma
2022 Standout
Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux
2007
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
A systematic review of intervention thresholds based on FRAX
2016
Less collagen production in smokers
1998
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease
1998
Bile in the oesophagus: Clinical relevance and ambulatory detection
1997
Inflammatory Muscle Diseases
2015 Standout
Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists
2002
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Three- to 4.5-Year Prospective Study of Prognostic Indicators in Gastro-oesophageal Reflux Disease
1998
Tailored interventions to address determinants of practice
2015 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
2012
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
2004
Quality Indicators for Colonoscopy
2006
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
ACG Clinical Guideline: Ulcerative Colitis in Adults
2019
Global Epidemiology of Campylobacter Infection
2015 Standout
Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding
2009
A Sampling of Canadian Practice in Managing Nonvariceal Upper Gastrointestinal Bleeding before Recent Guideline Publication: Is there Room for Improvement?
2005
The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux Disease
1998
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Cost-Effectiveness of Proton-Pump Inhibition Before Endoscopy in Upper Gastrointestinal Bleeding
2008
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
2009
Diabetic Autonomic Neuropathy
2003 Standout
A Canadian Physician Survey of Dyspepsia Management
1998
Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
2004
The Role of Rapid Endoscopy for High-Risk Patients with Acute Nonvariceal Upper Gastrointestinal Bleeding
2007
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
2013
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of David Armstrong being referenced
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
2000
Nocturnal oesophageal motor activity is dependent on sleep stage.
1993
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.
1995
Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group.
1993
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.
1994
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
1999 Standout
Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body Myositis
2004
Cancer Care Ontario Colonoscopy Standards: Standards and Evidentiary Base
2007
The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts
1998
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria
2006
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
2013
Reflux Disease and Barrett's Oesophagus
1992
Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori ‐positive primary care patients with uninvestigated dyspepsia
2004
Effects of Omeprazole and Lansoprazole on 24-Hour Intragastric pH in Helicobacter pylori-Positive Volunteers
1994
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole
2004
Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial
2013
Heartburn‐dominant, uninvestigated dyspepsia: a comparison of ‘PPI‐start’ and ‘H2‐RA‐start’ management strategies in primary care – the CADET‐HR Study
2005
Fate of antacid gel in the stomach
1990
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months
2002
Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia
2004
Efficacy of Topical Metronidazole (10 Percent) in the Treatment of Anorectal Crohn's Disease
2005
The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy
2006
Methods to study gastric emptying
1994
Do we need a new gastro‐oesophageal reflux disease questionnaire?
2004
The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach
2000
Intragastric pH during Treatment with Omeprazole: Role ofHelicobacter pyloriandH. pylori-Associated Gastritis
1996
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
2015
Infection with Helicobacter pylori.
1996
Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis?
2005
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study
2003
Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn
2003
Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects
2006
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting
2004
The endoscopic assessment of esophagitis: A progress report on observer agreement
1996
Economic Analysis of Home vs Hospital‐Based Parenteral Nutrition in Ontario, Canada
2005
A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study
2005
Helicobacter pyloriInfection and Dyspepsia
1996
Common bile duct obstruction secondary to infection with Candida
1978
Endoscopic evaluation of gastro-esophageal reflux disease.
2000
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.
1995
Convolutional neural networks for medical image analysis: State-of-the-art, comparisons, improvement and perspectives
2021
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.
2000
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Helicobacter pylori infection and dyspepsia.
1996
Clinical Onset of Celiac Disease after an Episode ofCampylobacter jejuniEnteritis
2007
An amperometric enzyme electrode for bile acids
1993
Predictors of treatment response and relapse for heartburn-dominant uninvestigated dyspepsia (HBDUD) in primary care practice (PCP): the CADET-HR study
2002
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease1
2001
Intravenous acid suppression — Appropriateness of use in a tertiary care setting
2001
Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool
2005
Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement
2012
Initial management strategies for reflux-predominant uninvestigated dyspepsia (UD) in primary care practice-the CADET-HR study
2001
Intravenous proton pump inhibitor therapy: a rationale for use.
2005